XML 18 R4.htm IDEA: XBRL DOCUMENT v3.19.1
CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS
¥ in Thousands, $ in Thousands
12 Months Ended
Dec. 31, 2018
CNY (¥)
¥ / shares
shares
Dec. 31, 2018
USD ($)
$ / shares
shares
Dec. 31, 2017
CNY (¥)
¥ / shares
shares
Dec. 31, 2016
CNY (¥)
¥ / shares
shares
Revenues, net of business tax, value-added tax and related surcharges ¥ 190,898 $ 27,765 ¥ 330,977 ¥ 455,042
Equipment leasing revenues 76,723 11,159 239,569 379,559
Services and other revenues 114,175 16,606 91,408 75,483
Cost of revenues (171,136) (24,891) (232,979) (286,543)
Gross profit 19,762 2,874 97,998 168,499
Operating expenses:        
Selling expenses (21,718) (3,159) (43,608) (70,093)
General and administrative expenses (291,854) (42,448) (237,646) (205,908)
Impairment of long-lived assets (5,433) (790) (28,600) (61,124)
Operating loss (299,243) (43,523) (211,856) (168,626)
Interest expense (including interest expense to related party amounting to RMB15,073, RMB46,355 and RMB7,150 (US$1,040) for the years ended December 31, 2016, 2017 and 2018, respectively) (46,232) (6,724) (89,959) (89,327)
Foreign exchange gain, net 36,531 5,313 4,023 13,472
(Loss) gain on disposal of long-lived assets 4,711 685 (31,437) (7,619)
Interest income 14,168 2,061 12,077 27,982
Changes in fair value of derivatives 0 0 0 713
Income (loss) from equity method investments (20,747) (3,018) 1,454 616
Gain on disposal of subsidiaries 3,341 486 58,913 0
Other income, net 34,206 4,975 2,890 18,191
Gain on disposal of an equity method investment 48,019 6,984 0 0
Loss before income tax (225,246) (32,761) (253,895) (204,598)
Income tax expenses (34,051) (4,953) (31,789) (60,486)
Net loss (259,297) (37,714) (285,684) (265,084)
Net loss attributable to noncontrolling interests (24,422) (3,552) (1,364) (3,217)
Net loss attributable to Concord Medical Services Holdings Limited ¥ (234,875) $ (34,162) ¥ (284,320) ¥ (261,867)
Loss per share for Class A and Class B ordinary shares:        
Basic and diluted | (per share) ¥ (2.76) $ (0.40) ¥ (2.19) ¥ (2.00)
Weighted average number of class A and class B ordinary shares outstanding:        
Basic and diluted 130,104,787 130,104,787 130,091,977 130,631,867
Other comprehensive (loss) income, net of tax of nil        
Foreign currency translation, net tax of nil ¥ (41,203) $ (5,993) ¥ 40,550 ¥ (41,394)
Total other comprehensive (loss) income, net of tax (41,203) (5,993) 40,550 (41,394)
Comprehensive loss (300,500) (43,707) (245,134) (306,478)
Comprehensive (loss) income attributable to noncontrolling interests (22,902) (3,331) 2,485 (6,740)
Comprehensive loss attributable to Concord Medical Services Holdings Limited ¥ (277,598) $ (40,376) ¥ (247,619) ¥ (299,738)